Improving appropriate use of anticoagulants in hospitalised patients: A pharmacist‐led Check of Medication Appropriateness intervention

摘要

Aims Inappropriate anticoagulant use increases the risk of bleeding and thrombotic events. We implemented clinical decision rules to promote judicious medication use, as part of the ‘Check of Medication Appropriateness’ (CMA). The CMA is a pharmacist‐led review service, targeting potentially inappropriate prescriptions (PIPs). In this analysis, we aimed to evaluate the impact of the CMA on anticoagulant prescribing. Methods The number of anticoagulant‐related PIPs was evaluated before and after implementation of the intervention in a quasi‐experimental interrupted time series analysis. The pre‐implementation cohort received usual care. The anticoagulant‐focused CMA, comprising 13 clinical rules pertaining to anticoagulation therapies, was implemented in the post‐implementation cohort. Segmented regression analysis was used to assess the impact of the intervention on the number of residual PIPs. A residual PIP was defined as a PIP which persisted up to 48?hours after the CMA intervention. Total number of recommendations and acceptance rate were documented for the 2‐year post‐implementation period. Results Pre‐implementation, we observed 501 PIPs in 466 inpatients on 36?days, with a median proportion of 78.5 (range: 46.2–100) residual PIPs per day. Post‐implementation, 538 PIPs were detected in 485 patients over the same number of days. The CMA intervention reduced the median proportion to 18.2 (range: 0–100) per day. The effect coincided with an immediate relative reduction of 70 (95CI 0.19–0.46) in anticoagulant‐related residual PIPs. Post‐implementation, 2778 recommendations were provided and 75.1 were accepted. Conclusion Our CMA approach significantly reduced anticoagulant‐related PIPs. Implementing a pharmacist‐led intervention, based on clinical rules, may support safer prescribing of anticoagulants.